Intrust Bank’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,342
| Closed | -$404K | – | 379 |
|
|
2021
Q1 | $404K | Buy |
4,342
+130
| +3% | +$12.1K | 0.06% | 258 |
|
|
2020
Q4 | $378K | Sell |
4,212
-1
| -0% | -$90 | 0.06% | 251 |
|
|
2020
Q3 | $436K | Sell |
4,213
-399
| -9% | -$41.3K | 0.08% | 202 |
|
|
2020
Q2 | $365K | Buy |
4,612
+408
| +10% | +$32.3K | 0.07% | 233 |
|
|
2020
Q1 | $243K | Buy |
+4,204
| New | +$243K | 0.07% | 266 |
|
|
2019
Q1 | – | Sell |
-4,762
| Closed | -$283K | – | 376 |
|
|
2018
Q4 | $283K | Buy |
4,762
+127
| +3% | +$7.55K | 0.08% | 281 |
|
|
2018
Q3 | $305K | Hold |
4,635
| – | – | 0.08% | 290 |
|
|
2018
Q2 | $234K | Buy |
+4,635
| New | +$234K | 0.06% | 328 |
|
|
2016
Q3 | – | Sell |
-9,550
| Closed | -$268K | – | 338 |
|
|
2016
Q2 | $268K | Buy |
+9,550
| New | +$268K | 0.11% | 278 |
|